C9 and B-cell chronic lymphocytic leukemia: The serum levels of C components have been studied in CLL patients, showing that in 70% of the patients, the level of at least one of the studied proteins (C1- C9, Factor B and properdin) was decreased [4], in correlation with the stage of the disease.